155 related articles for article (PubMed ID: 26878784)
41. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
42. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
43. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.
Greger JG; Fursov N; Cooch N; McLarney S; Freedman LP; Edwards DP; Cheskis BJ
Mol Cell Biol; 2007 Mar; 27(5):1904-13. PubMed ID: 17194752
[TBL] [Abstract][Full Text] [Related]
44. Unliganded estrogen receptor alpha inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21(WAF1)).
Maynadier M; Ramirez JM; Cathiard AM; Platet N; Gras D; Gleizes M; Sheikh MS; Nirde P; Garcia M
FASEB J; 2008 Mar; 22(3):671-81. PubMed ID: 17911387
[TBL] [Abstract][Full Text] [Related]
45. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
Yu Y; Zhou Q; Hang Y; Bu X; Jia W
Cancer; 2007 Jun; 109(11):2374-82. PubMed ID: 17464948
[TBL] [Abstract][Full Text] [Related]
46. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
[TBL] [Abstract][Full Text] [Related]
47. Kaempferol suppresses human gastric cancer SNU-216 cell proliferation, promotes cell autophagy, but has no influence on cell apoptosis.
Zhang F; Ma C
Braz J Med Biol Res; 2019 Feb; 52(2):e7843. PubMed ID: 30785478
[TBL] [Abstract][Full Text] [Related]
48. Tyrosine phosphatase Shp2 mediates the estrogen biological action in breast cancer via interaction with the estrogen extranuclear receptor.
Li J; Kang Y; Wei L; Liu W; Tian Y; Chen B; Lin X; Li Y; Feng GS; Lu Z
PLoS One; 2014; 9(7):e102847. PubMed ID: 25048202
[TBL] [Abstract][Full Text] [Related]
49. Triclosan Lacks Anti-Estrogenic Effects in Zebrafish Cells but Modulates Estrogen Response in Zebrafish Embryos.
Serra H; Brion F; Porcher JM; Budzinski H; Aït-Aïssa S
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649157
[TBL] [Abstract][Full Text] [Related]
50. KAEMPFEROL, A FLAVONOID COMPOUND FROM
Yi X; Zuo J; Tan C; Xian S; Luo C; Chen S; Yu L; Luo Y
Afr J Tradit Complement Altern Med; 2016; 13(4):210-215. PubMed ID: 28852738
[TBL] [Abstract][Full Text] [Related]
51. Kaempferol inhibits the growth and metastasis of cholangiocarcinoma in vitro and in vivo.
Qin Y; Cui W; Yang X; Tong B
Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):238-45. PubMed ID: 26883800
[TBL] [Abstract][Full Text] [Related]
52. The in vitro estrogenic activities of triclosan and triclocarban.
Huang H; Du G; Zhang W; Hu J; Wu D; Song L; Xia Y; Wang X
J Appl Toxicol; 2014 Sep; 34(9):1060-7. PubMed ID: 24740835
[TBL] [Abstract][Full Text] [Related]
53. An integrated approach of network pharmacology, molecular docking, and experimental verification uncovers kaempferol as the effective modulator of HSD17B1 for treatment of endometrial cancer.
Ruan GY; Ye LX; Lin JS; Lin HY; Yu LR; Wang CY; Mao XD; Zhang SH; Sun PM
J Transl Med; 2023 Mar; 21(1):204. PubMed ID: 36932403
[TBL] [Abstract][Full Text] [Related]
54.
Yoon KS; Kwack SJ
J Toxicol Environ Health A; 2021 Oct; 84(19):800-809. PubMed ID: 34193021
[TBL] [Abstract][Full Text] [Related]
55. Endocrine Disrupting Effects of Triclosan on the Placenta in Pregnant Rats.
Feng Y; Zhang P; Zhang Z; Shi J; Jiao Z; Shao B
PLoS One; 2016; 11(5):e0154758. PubMed ID: 27149376
[TBL] [Abstract][Full Text] [Related]
56. Kaempferol-zinc(II) complex synthesis and evaluation of bone formation using zebrafish model.
Vimalraj S; Saravanan S; Hariprabu G; Yuvashree R; Ajieth Kanna SK; Sujoy K; Anjali D
Life Sci; 2020 Sep; 256():117993. PubMed ID: 32574664
[TBL] [Abstract][Full Text] [Related]
57. Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition.
Kim BW; Lee ER; Min HM; Jeong HS; Ahn JY; Kim JH; Choi HY; Choi H; Kim EY; Park SP; Cho SG
Cancer Biol Ther; 2008 Jul; 7(7):1080-9. PubMed ID: 18443432
[TBL] [Abstract][Full Text] [Related]
58. IQ Motif Containing GTPase-Activating Protein 3 (IQGAP3) Inhibits Kaempferol-Induced Apoptosis in Breast Cancer Cells by Extracellular Signal-Regulated Kinases 1/2 (ERK1/2) Signaling Activation.
Hu G; Liu H; Wang M; Peng W
Med Sci Monit; 2019 Oct; 25():7666-7674. PubMed ID: 31605603
[TBL] [Abstract][Full Text] [Related]
59. Effect of Estrogen on Heteronemin-Induced Anti-proliferative Effect in Breast Cancer Cells With Different Estrogen Receptor Status.
Yang YSH; Li ZL; Huang TY; Su KW; Lin CY; Huang CH; Chen HY; Lu MC; Huang HM; Lee SY; Whang-Peng J; Lin HY; Davis PJ; Wang K
Front Cell Dev Biol; 2021; 9():688607. PubMed ID: 34381775
[TBL] [Abstract][Full Text] [Related]
60. Comparison of hepatotoxicity and mechanisms induced by triclosan (TCS) and methyl-triclosan (MTCS) in human liver hepatocellular HepG2 cells.
Wang L; Mao B; He H; Shang Y; Zhong Y; Yu Z; Yang Y; Li H; An J
Toxicol Res (Camb); 2019 Jan; 8(1):38-45. PubMed ID: 30713659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
